iShares Health Innovation Active ETF (BMED)

Assets	$10.94M
Expense Ratio	0.55%
PE Ratio	27.75
Shares Out	360,000
Dividend (ttm)	$0.08
Dividend Yield	0.26%
Ex-Dividend Date	Jun 15, 2026
Payout Frequency	n/a
Payout Ratio	7.41%

Volume	1,541
Open	30.82
Previous Close	30.76
Day's Range	30.82 - 30.85
52-Week Low	24.50
52-Week High	32.19
Beta	0.73
Holdings	62
Inception Date	Sep 29, 2020

About BMED

Fund Home Page

The iShares Health Innovation Active ETF (BMED) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: BMED
• ETF Provider: BlackRock

Top 10 Holdings

42.03% of assets

Name	Symbol	Weight
Merck & Co., Inc.	MRK	5.82%
Gilead Sciences, Inc.	GILD	5.11%
Edwards Lifesciences Corporation	EW	4.53%
Johnson & Johnson	JNJ	4.40%
Thermo Fisher Scientific Inc.	TMO	3.97%
Danaher Corporation	DHR	3.84%
Charles River Laboratories International, Inc.	CRL	3.68%
Biogen Inc.	BIIB	3.64%
Waters Corporation	WAT	3.53%
AbbVie Inc.	ABBV	3.50%

Dividend History

Ex-Dividend	Amount	Pay Date
Jun 15, 2026	$0.08118	Jun 18, 2026
Dec 20, 2023	$0.00721	Dec 27, 2023

Performance

BMED had a total return of 21.84% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.29%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Jul 24, 2026

Data Sources Report a data error